Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 1
1981 2
1982 2
1983 1
1984 1
1985 2
1988 1
1989 1
1990 1
1991 1
1992 2
1993 2
1994 1
1996 1
1997 3
1998 2
1999 2
2001 2
2002 3
2003 6
2004 4
2005 9
2006 2
2008 2
2009 2
2010 3
2011 1
2012 2
2013 3
2014 5
2015 6
2016 11
2017 2
2018 2
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Outrageous prices of orphan drugs: a call for collaboration.
Luzzatto L, Hyry HI, Schieppati A, Costa E, Simoens S, Schaefer F, Roos JCP, Merlini G, Kääriäinen H, Garattini S, Hollak CE, Remuzzi G; Second Workshop on Orphan Drugs participants. Luzzatto L, et al. Among authors: schieppati a. Lancet. 2018 Sep 1;392(10149):791-794. doi: 10.1016/S0140-6736(18)31069-9. Epub 2018 Jul 20. Lancet. 2018. PMID: 30037734 No abstract available.
The future of renoprotection.
Perico N, Codreanu I, Schieppati A, Remuzzi G. Perico N, et al. Among authors: schieppati a. Kidney Int Suppl. 2005 Aug;(97):S95-101. doi: 10.1111/j.1523-1755.2005.09716.x. Kidney Int Suppl. 2005. PMID: 16014108 Free article. Review.
Rare autoimmune diseases.
Schieppati A, Daina E. Schieppati A, et al. Adv Exp Med Biol. 2010;686:365-74. doi: 10.1007/978-90-481-9485-8_21. Adv Exp Med Biol. 2010. PMID: 20824456 Review.
Orphan drugs - Authors' reply.
Luzzatto L, Costa E, Schieppati A, Remuzzi G. Luzzatto L, et al. Among authors: schieppati a. Lancet. 2019 Apr 20;393(10181):1595-1596. doi: 10.1016/S0140-6736(19)30014-5. Lancet. 2019. PMID: 31007199 No abstract available.
Novel therapies of lupus nephritis.
Schieppati A, Remuzzi G. Schieppati A, et al. Curr Opin Nephrol Hypertens. 2008 Mar;17(2):156-61. doi: 10.1097/MNH.0b013e3282f4e54d. Curr Opin Nephrol Hypertens. 2008. PMID: 18277148 Review.
Why rare diseases?
Remuzzi G, Schieppati A. Remuzzi G, et al. Among authors: schieppati a. Ann Ist Super Sanita. 2011;47(1):94-7. doi: 10.4415/ANN_11_01_18. Ann Ist Super Sanita. 2011. PMID: 21430346 Free article. Review.
[Drugs for rare diseases: the blessing of being orphans.].
Costa E, Schieppati A, Luzzatto L, Remuzzi G. Costa E, et al. Among authors: schieppati a. Recenti Prog Med. 2019 May;110(5):221-229. doi: 10.1701/3163.31444. Recenti Prog Med. 2019. PMID: 31140454 Review. Italian.
91 results